Search research articles
Contact Us
Filters
Showing results (371-380 of 401) with videos related to
Page
of 41
Sort By:
Biochemical Pharmacology
|
October 5, 2013
SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation
Qian Liu, Huafei Wu, Shek Man Chim, et al.
Scientific Reports
|
November 9, 2016
Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation
Qian Liu, Tao Wang, Lin Zhou, et al.
Journal of Advanced Research
|
January 18, 2025
Transcriptional regulation of Rankl by Txnip-Ecd in aging and diabetic related osteoporosis
Xiankun Cao, Kexin Liu, Jinbo Yuan, et al.
Bioactive Materials
|
December 17, 2025
Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis
Qihang Wu, Jiansen Miao, Yu Chen, et al.
Journal of Cellular Physiology
|
September 23, 2020
A missense mutation sheds light on a novel structure-function relationship of RANKL
Heng Qiu, An Qin, Taksum Cheng, et al.
Frontiers in Pharmacology
|
February 7, 2022
Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
Gang Wang, Chao Ma, Kai Chen, et al.
Molecular and Cellular Endocrinology
|
December 3, 2014
Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model
Jianbin Huang, Lin Zhou, Huafei Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 5, 2024
Bone-protective effects of neutralizing angiopoietin-like protein 4 monoclonal antibody in rheumatoid arthritis
Liqing Ke, Qifei He, Jing Qu, et al.
Journal of Cellular Physiology
|
March 1, 2019
Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways
Zuoxing Wu, Hailun Wu, Chen Li, et al.
Pharmacological Research
|
May 27, 2020
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
Delong Chen, Zhen Ye, Chao Wang, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 401) with videos related to
Sort By:
Page
of 41
Biochemical Pharmacology
|
October 5, 2013
SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation
Qian Liu, Huafei Wu, Shek Man Chim, et al.
Scientific Reports
|
November 9, 2016
Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation
Qian Liu, Tao Wang, Lin Zhou, et al.
Journal of Advanced Research
|
January 18, 2025
Transcriptional regulation of Rankl by Txnip-Ecd in aging and diabetic related osteoporosis
Xiankun Cao, Kexin Liu, Jinbo Yuan, et al.
Bioactive Materials
|
December 17, 2025
Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis
Qihang Wu, Jiansen Miao, Yu Chen, et al.
Journal of Cellular Physiology
|
September 23, 2020
A missense mutation sheds light on a novel structure-function relationship of RANKL
Heng Qiu, An Qin, Taksum Cheng, et al.
Frontiers in Pharmacology
|
February 7, 2022
Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
Gang Wang, Chao Ma, Kai Chen, et al.
Molecular and Cellular Endocrinology
|
December 3, 2014
Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model
Jianbin Huang, Lin Zhou, Huafei Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 5, 2024
Bone-protective effects of neutralizing angiopoietin-like protein 4 monoclonal antibody in rheumatoid arthritis
Liqing Ke, Qifei He, Jing Qu, et al.
Journal of Cellular Physiology
|
March 1, 2019
Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways
Zuoxing Wu, Hailun Wu, Chen Li, et al.
Pharmacological Research
|
May 27, 2020
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation
Delong Chen, Zhen Ye, Chao Wang, et al.
Page
of 41